-
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Hold" by Analysts
Source: Buzz FX / 05 Oct 2024 04:56:10 America/Chicago
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Average Rating of "Hold" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Aclaris Therapeutics, Inc. ( NASDAQ:ACRS - Get Free Report ) have been given
Read more...